Exosomal miR92a Promotes Cytarabine Resistance in Myelodysplastic Syndromes by Activating Wnt/β-catenin Signal Pathway

Cytarabine (Ara-C) has been one of the frontline therapies for clonal hematopoietic stem cell disorders, such as myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), but Ara-C resistance often occurs and leads to treatment failure. Exosomal microRNAs (miRNAs, miRs) as small noncoding RNA...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Hongjiao Li, Chenglian Xie, Yurong Lu, Kaijing Chang, Feng Guan, Xiang Li
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2022-10-01
Serija:	Biomolecules
Teme:	MDS/AML exosomal miR92a Ara-C resistance PTEN Wnt/β-catenin
Online dostop:	https://www.mdpi.com/2218-273X/12/10/1448
Oznake:	Označite Brez oznak, prvi označite!